These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26240956)

  • 21. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
    Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
    Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Models for evaluating the pharmacokinetics and pharmacodynamics for β-blockers.
    Höcht C; Bertera FM; Del Mauro JS; Taira CA
    Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):525-41. PubMed ID: 24593316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of drugs in pediatrics using K-PD models: perspectives.
    Tod M
    Fundam Clin Pharmacol; 2008 Dec; 22(6):589-94. PubMed ID: 19049659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic-pharmacodynamic population modelling in paediatric anaesthesia and its clinical translation.
    Morse JD; Hannam J; Anderson BJ
    Curr Opin Anaesthesiol; 2019 Jun; 32(3):353-362. PubMed ID: 31045640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.
    Toutain PL
    AAPS PharmSci; 2002; 4(4):E38. PubMed ID: 12646010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tools for predicting the PK/PD of therapeutic proteins.
    Diao L; Meibohm B
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1115-25. PubMed ID: 25936400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacodynamic and pharmacokinetic modeling via mixed effects.
    Piotrovsky VK
    Curr Opin Drug Discov Devel; 2000 May; 3(3):314-30. PubMed ID: 19649865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
    Lees P; Giraudel J; Landoni MF; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic-pharmacodynamic modeling in anesthesia, intensive care and pain medicine.
    Sadean MR; Glass PS
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):463-8. PubMed ID: 19412091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of pharmacokinetic-pharmacodynamic relationships in drug development].
    Bellissant E; Courcier-Duplantier S; Blin O;
    Therapie; 2002; 57(4):347-57. PubMed ID: 12422555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permutation auto-mutual information of electroencephalogram in anesthesia.
    Liang Z; Wang Y; Ouyang G; Voss LJ; Sleigh JW; Li X
    J Neural Eng; 2013 Apr; 10(2):026004. PubMed ID: 23370095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic-pharmacodynamic model for educational simulations.
    van Meurs WL; Nikkelen E; Good ML
    IEEE Trans Biomed Eng; 1998 May; 45(5):582-90. PubMed ID: 9581056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different pharmacodynamic models for PK-PD modeling of verapamil in renovascular hypertension.
    Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
    J Pharmacol Toxicol Methods; 2008; 57(3):212-9. PubMed ID: 18442930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design.
    Reddy MB; Yang KH; Rao G; Rayner CR; Nie J; Pamulapati C; Marathe BM; Forrest A; Govorkova EA
    PLoS One; 2015; 10(10):e0138069. PubMed ID: 26460484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential allocation trial design in anesthesia: an introduction to methods, modeling, and clinical applications.
    Görges M; Zhou G; Brant R; Ansermino JM
    Paediatr Anaesth; 2017 Mar; 27(3):240-247. PubMed ID: 28211193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic interactions in anaesthesia. A review of current knowledge and how it can be used to optimize anaesthetic drug administration.
    van den Berg JP; Vereecke HE; Proost JH; Eleveld DJ; Wietasch JK; Absalom AR; Struys MM
    Br J Anaesth; 2017 Jan; 118(1):44-57. PubMed ID: 28039241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase.
    Palani S; Patel M; Huck J; Zhang M; Balani SK; Yang J; Chen S; Mettetal J; Manfredi M; Shyu WC; Ecsedy JA; Chakravarty A
    Cancer Chemother Pharmacol; 2013 Dec; 72(6):1255-64. PubMed ID: 24101146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.
    Zobell JT; Stockmann C; Young DC; Cash J; McDowell BJ; Korgenski K; Sherwin CM; Spigarelli M; Chatfield BA; Ampofo K
    Clin Ther; 2011 Nov; 33(11):1844-50. PubMed ID: 22018680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.